240 related articles for article (PubMed ID: 30599067)
1. Transcriptional repression of the ectodomain sheddase ADAM10 by TBX2 and potential implication for Alzheimer's disease.
Reinhardt S; Schuck F; Stoye N; Hartmann T; Grimm MOW; Pflugfelder G; Endres K
Cell Mol Life Sci; 2019 Mar; 76(5):1005-1025. PubMed ID: 30599067
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor apicidin increases expression of the α-secretase ADAM10 through transcription factor USF1-mediated mechanisms.
Hu XT; Zhu BL; Zhao LG; Wang JW; Liu L; Lai YJ; He L; Deng XJ; Chen GJ
FASEB J; 2017 Apr; 31(4):1482-1493. PubMed ID: 28003340
[TBL] [Abstract][Full Text] [Related]
3. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
[TBL] [Abstract][Full Text] [Related]
4. Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.
Colombo A; Wang H; Kuhn PH; Page R; Kremmer E; Dempsey PJ; Crawford HC; Lichtenthaler SF
Neurobiol Dis; 2013 Jan; 49():137-47. PubMed ID: 22940630
[TBL] [Abstract][Full Text] [Related]
5. Extracellular-Signal-Regulated Kinase Inhibition Switches APP Processing from β- to α-Secretase under Oxidative Stress: Modulation of ADAM10 by SIRT1/NF-κB Signaling.
Thonda S; Puttapaka SN; Kona SV; Kalivendi SV
ACS Chem Neurosci; 2021 Nov; 12(21):4175-4186. PubMed ID: 34647720
[TBL] [Abstract][Full Text] [Related]
6. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
8. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.
Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K
PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847
[TBL] [Abstract][Full Text] [Related]
9. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain.
Marcinkiewicz M; Seidah NG
J Neurochem; 2000 Nov; 75(5):2133-43. PubMed ID: 11032903
[TBL] [Abstract][Full Text] [Related]
10. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
Ilievski V; Zuchowska PK; Green SJ; Toth PT; Ragozzino ME; Le K; Aljewari HW; O'Brien-Simpson NM; Reynolds EC; Watanabe K
PLoS One; 2018; 13(10):e0204941. PubMed ID: 30281647
[TBL] [Abstract][Full Text] [Related]
11. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
12. α-secretase ADAM10 physically interacts with β-secretase BACE1 in neurons and regulates CHL1 proteolysis.
Wang X; Wang C; Pei G
J Mol Cell Biol; 2018 Oct; 10(5):411-422. PubMed ID: 29325091
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
[TBL] [Abstract][Full Text] [Related]
14. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10.
Augustin R; Endres K; Reinhardt S; Kuhn PH; Lichtenthaler SF; Hansen J; Wurst W; Trümbach D
BMC Med Genet; 2012 May; 13():35. PubMed ID: 22594617
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of the A disintegrin and metalloproteinase 10 (ADAM10) by the tetraspanin 15.
Seipold L; Altmeppen H; Koudelka T; Tholey A; Kasparek P; Sedlacek R; Schweizer M; Bär J; Mikhaylova M; Glatzel M; Saftig P
Cell Mol Life Sci; 2018 Sep; 75(17):3251-3267. PubMed ID: 29520422
[TBL] [Abstract][Full Text] [Related]
18. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
[TBL] [Abstract][Full Text] [Related]
20. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
